- Home
- IOVA vs FIP Comparison
IOVA vs FIP Comparison
Compare IOVA & FIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- FIP
- Stock Information
- Founded
- IOVA 2007
- FIP 2021
- Country
- IOVA United States
- FIP United States
- Employees
- IOVA N/A
- FIP N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- FIP Consumer Electronics/Appliances
- Sector
- IOVA Health Care
- FIP Industrials
- Exchange
- IOVA Nasdaq
- FIP Nasdaq
- Market Cap
- IOVA 975.1M
- FIP 822.8M
- IPO Year
- IOVA N/A
- FIP N/A
- Fundamental
- Price
- IOVA $2.69
- FIP $5.32
- Analyst Decision
- IOVA Buy
- FIP Buy
- Analyst Count
- IOVA 11
- FIP 1
- Target Price
- IOVA $11.90
- FIP $12.00
- AVG Volume (30 Days)
- IOVA 16.7M
- FIP 3.3M
- Earning Date
- IOVA 08-07-2025
- FIP 08-07-2025
- Dividend Yield
- IOVA N/A
- FIP 2.26%
- EPS Growth
- IOVA N/A
- FIP N/A
- EPS
- IOVA N/A
- FIP N/A
- Revenue
- IOVA $241,525,000.00
- FIP $382,522,000.00
- Revenue This Year
- IOVA $86.62
- FIP $65.61
- Revenue Next Year
- IOVA $69.13
- FIP $30.50
- P/E Ratio
- IOVA N/A
- FIP N/A
- Revenue Growth
- IOVA 636.99
- FIP 16.07
- 52 Week Low
- IOVA $1.64
- FIP $3.10
- 52 Week High
- IOVA $12.51
- FIP $9.99
- Technical
- Relative Strength Index (RSI)
- IOVA 54.92
- FIP 46.79
- Support Level
- IOVA $2.44
- FIP $4.39
- Resistance Level
- IOVA $2.85
- FIP $4.89
- Average True Range (ATR)
- IOVA 0.24
- FIP 0.51
- MACD
- IOVA -0.00
- FIP -0.06
- Stochastic Oscillator
- IOVA 83.16
- FIP 26.34
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About FIP FTAI Infrastructure Inc.
FTAI Infrastructure Inc is engaged in five segments; Railroad segment includes five freight railroads and one switching company that provide rail service to certain manufacturing and production facilities, the Jefferson Terminal segment consists of a multi-modal crude oil and refined products terminal and other related assets. Repauno segment consists of a 1,630-acre deep-water port located along the Delaware River with an underground storage cavern, a new multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities. Power and Gas segment is comprised of an equity method investment in Long Ridge, and Sustainability and Energy Transition segment is comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.